首页 › 基金 › Ikarian Capital, LLC › KZIA

Ikarian Capital, LLC 对 KZIA 的持仓历史

KAZIA THERAPEUTICS LTD · 医疗保健

Ikarian Capital, LLC 在 Q2 2026 的 13F 申报中披露持有 KZIA(KAZIA THERAPEUTICS LTD)396,201 股,市值约 US$5.6M,约占其申报组合的 0.90%,在其申报持仓中市值排名第 37 位。 Ikarian Capital, LLC 于 Q2 2026 首次申报该持仓。

最新持仓 (Q2 2026)396.20K 股
申报持仓市值$5.58M
组合权重0.90%
首次申报Q2 2026
最近变动新进
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

Ikarian Capital, LLC 对 KZIA 的持仓演变

Ikarian Capital, LLC 于 Q2 2026 首次披露 KZIA 持仓:396,201 股(约 US$5.6M)。

逐季持仓明细

季度股数金额变化
Q2 2026 396.20K $5.58M 新进

关于 KZIA 与 13F 数据

KZIA(KAZIA THERAPEUTICS LTD)属于医疗保健行业。我们追踪的基金中还有 41 只申报持有 KZIA,申报仓位最大的包括:Boxer Capital Management, LLC (US$7.9M), Bleichroeder LP (US$5.6M), Dauntless Investment Group, LLC (US$5.0M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 KZIA 的基金

查看 KZIA 的全部基金持有人 →

常见问题

How long has Ikarian Capital, LLC held KZIA?

Ikarian Capital, LLC has disclosed KZIA holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is Ikarian Capital, LLC's current position in KZIA?

As of Q2 2026, Ikarian Capital, LLC holds 396.20K shares of KZIA (KAZIA THERAPEUTICS LTD), valued at $5.58M, representing 0.90% of its reported portfolio and ranking #37.

Has Ikarian Capital, LLC been buying or selling KZIA?

In the latest 13F filing (Q2 2026), Ikarian Capital, LLC newly opened its position in KZIA.

Which other funds hold KZIA?

Other major institutional holders of KZIA include Boxer Capital Management, LLC, Bleichroeder LP, Dauntless Investment Group, LLC, among 41 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.